Application of biomarkers in cancer risk management: Evaluation from stochastic clonal evolutionary and dynamic system optimization points of view

PLoS Computational Biology

Volumn 7, Issue 2, 2011, Pages

  Li, Xiaohong ^a   Blount, Patricia L ^a,b   Vaughan, Thomas L ^a   Reid, Brian J ^a,b,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMARKERS; DISEASES; FORECASTING; MOLECULAR BIOLOGY; STOCHASTIC SYSTEMS;

AT-RISK POPULATION; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; GENOMICS TECHNOLOGIES; RISKS MANAGEMENT; SCREENING MODELS; SOLID CANCER; STOCHASTICS; SYSTEM OPTIMIZATIONS;

RISK MANAGEMENT;

BIOLOGICAL MARKER; TUMOR MARKER;

ARTICLE; CANCER CONTROL; CANCER DIAGNOSIS; CANCER GROWTH; CANCER MORTALITY; CANCER RISK; CLINICAL PRACTICE; COPY NUMBER VARIATION; EARLY DIAGNOSIS; EPIGENETICS; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOSITY LOSS; HIGH RISK POPULATION; HUMAN; MATHEMATICAL MODEL; MOLECULAR BIOLOGY; MUTATIONAL ANALYSIS; PREDICTION; RISK ASSESSMENT; RISK MANAGEMENT; RISK REDUCTION; SOLID TUMOR; STOCHASTIC MODEL; DISEASE MANAGEMENT; METABOLISM; NEOPLASM; PREDICTIVE VALUE; RISK FACTOR; STATISTICS; SYSTEMS BIOLOGY;

DISEASE MANAGEMENT; HUMANS; NEOPLASMS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STOCHASTIC PROCESSES; SYSTEMS BIOLOGY; TUMOR MARKERS, BIOLOGICAL;

EID: 79952469410     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1001087     Document Type: Article

References (48)

1. Wingo PA, Ries LA, Rosenberg HM, Miller DS, Edwards BK, (1998) Cancer incidence and mortality, 1973-1995: a report card for the U.S. Cancer 82: 1197-1207.
2. Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, et al. (2003) The Case for Early Detection. Nature Reviews Cancer Volume 3: 1-10.
3. Jemal A, Clegg LX, Ward E, Ries LA, Wu X, et al. (2004) Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 101: 3-27.
4. O'Connell JB, Maggard MA, Ko CY, (2004) Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 96: 1420-1425.
5. Zelen M, (1993) Optimal scheduling of examinations for the early detection of disease. Biometrika 80: 279-293.
6. Prorok PC, (1976) The theory of periodic screening I. Lead time and proportion detected. Advances in applied probability 8: 127-143.
7. Croce CM, (2008) Oncogenes and cancer. N Engl J Med 358: 502-511.
8. Esteller M, (2008) Epigenetics in cancer. N Engl J Med 358: 1148-1159.
9. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
10. Jones S, Chen WD, Parmigiani G, Diehl F, Beerenwinkel N, et al. (2008) Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci U S A 105: 4283-4288.
11. Robson ME, Storm CD, Weitzel J, Wollins DS, Offit K, (2010) American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 28: 893-901.
12. Diamandis EP, (2010) Cancer biomarkers: can we turn recent failures into success? J Natl Cancer Inst 102: 1462-1467.
13. Hanash SM, Pitteri SJ, Faca VM, (2008) Mining the plasma proteome for cancer biomarkers. Nature 452: 571-579.
14. Ransohoff DF, (2005) Bias as a threat to the validity of cancer molecular-marker research. Nat Rev Cancer 5: 142-149.
15. Gerges N, Rak J, Jabado N, (2010) New technologies for the detection of circulating tumour cells. Br Med Bull 94: 49-64.
16. Dettling M, Buhlmann P, (2003) Boosting for tumor classification with gene expression data. Bioinformatics 19: 1061-1069.
17. Handl J, Knowles J, Kell DB, (2005) Computational cluster validation in post-genomic data analysis. Bioinformatics 21: 3201-3212.
18. Natsoulis G, El Ghaoui L, Lanckriet GR, Tolley AM, Leroy F, et al. (2005) Classification of a large microarray data set: algorithm comparison and analysis of drug signatures. Genome Res 15: 724-736.
19. Nowell PC, (1976) The clonal evolution of tumor cell populations. Science 194: 23-28.
20. Fearon ER, Vogelstein B, (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
21. Barrett MT, Sanchez CA, Prevo LJ, Wong DJ, Galipeau PC, et al. (1999) Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Gen 22: 106-109.
22. Frank S, (2007) Dynamics of Cancer: Incidence, Inheritance, and Evolution. Princeton Princeton University Press.
23. Luebeck EG, Moolgavkar SH, (2002) Multistage carcinogenesis and the incidence of colorectal cancer. Proc Natl Acad Sci U S A 99: 15095-15100.
24. Nowak MA, Komarova NL, Sengupta A, Jallepalli PV, Shih I-M, et al. (2002) The role of chromosomal instability in tumor initiation. Proceedings of the National Academy of Sciences of the United States of America 99: 16226-16231.
25. Tan WY, (1991) Stochastic Models for Carcinogenesis. New York Marcel Dekker, Inc.
26. Yakovlev AY, Tsodikov AD, Asselain B, (1996) Stochastic models of tumor latency and their biostatistical applications. River Edge World Scientific Publishing Co.
27. Ao P, Galas D, Hood L, Yin L, Zhu XM, (2010) Towards predictive stochastic dynamical modeling of cancer genesis and progression. Interdiscip Sci 2: 140-144.
28. Ye CJ, Stevens JB, Liu G, Bremer SW, Jaiswal AS, et al. (2009) Genome based cell population heterogeneity promotes tumorigenicity: the evolutionary mechanism of cancer. J Cell Physiol 219: 288-300.
29. Li X, Galipeau PC, Sanchez CA, Blount PL, Maley CC, et al. (2008) Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression. Cancer Prev Res (Phila Pa) 1: 413-423.
30. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113.
31. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature 446: 153-158.
32. Weir BA, Woo MS, Getz G, Perner S, Ding L, et al. (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature 450: 893-898.
33. Tanemura A, Terando AM, Sim MS, van Hoesel AQ, de Maat MF, et al. (2009) CpG island methylator phenotype predicts progression of malignant melanoma. Clin Cancer Res 15: 1801-1807.
34. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, et al. (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463: 899-905.
35. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806.
36. Flehinger BJ, Kimmel M, (1987) The natural history of lung cancer in a periodically screened population. Biometrics 43: 127-144.
37. Lee SJ, Zelen M, (1998) Scheduling periodic examinations for the early detection of disease: Applications to breast cancer. Journal of the American Statistical Association 93: 1271-1281.
38. Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, et al. (2007) A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 356: 11-20.
39. Galipeau PC, Li X, Blount PL, Maley CC, Sanchez CA, et al. (2007) NSAIDs modulate CDKN2A, TP53, and DNA content risk for future esophageal adenocarcinoma. PLoS Med 4: e67 doi:10.1371/journal.pmed.0040067.
40. Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, et al. (2000) Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 6: 1702-1710.
41. Reid BJ, Li X, Galipeau PC, Vaughan TL, (2010) Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer 10: 87-101.
42. Shedden K, Taylor JM, Enkemann SA, Tsao MS, Yeatman TJ, et al. (2008) Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 14: 822-827.
43. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AAM, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-535.
44. Heng HH, Stevens JB, Lawrenson L, Liu G, Ye KJ, et al. (2008) Patterns of genome dynamics and cancer evolution. Cell Oncol 30: 513-514.
45. Siegmunda KD, Marjorama P, Woob Y, Tavare S, Shibatab D, (2008) Inferring clonal expansion and cancer stem cell dynamics from DNA methylation patterns in colorectal cancers. Proc Natl Acad Sci U S A 106: 4828-4833.
46. Heng HH, (2008) The conflict between complex systems and reductionism. JAMA 300: 1580-1581.
47. Sawyers CL, (2008) The cancer biomarker problem. Nature 452: 548-552.
48. Cohen JE, (2004) Mathematics is biology's next microscope, only better; biology is mathematics' next physics, only better. PLoS Biol 2: e439 doi:10.1371/journal.pbio.0020439.